Your session is about to expire
← Back to Search
Chemotherapy for Pancreatic Cancer
Study Summary
This trial looks at how well a certain chemotherapy treatment works in shrinking pancreatic tumors before surgery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My cancer has spread to distant parts of my body.My organs and bone marrow are functioning normally.I am 18 years old or older.My blood clotting status is within the safe range.My pancreatic cancer is confirmed and may or may not be removable by surgery.I am able to care for myself but may not be able to do active work.I have not had chemotherapy or radiation for pancreatic cancer.I have a history of lung conditions like sarcoidosis or pulmonary fibrosis.I do not have any ongoing serious infections requiring treatment.I have been diagnosed with HIV, hepatitis B, or hepatitis C.I have not had major surgery, except for a biopsy, in the last 4 weeks.You have had an allergic reaction or are highly sensitive to the study drugs.I am willing and able to follow the study's procedures.I don't use non-FDA approved cannabinoids and use no more than 40 mg of Marinol daily.I do not have any serious heart rhythm problems.My CA 19-9 levels are high, but my bilirubin is normal.
- Group 1: Treatment
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants have been accepted for this investigation?
"Affirmative. Per the information posted on clinicaltrials.gov, this medical research is presently looking for participants; it was initially advertised on December 1st 2020 and updated most recently in May 10th 2022. 12 individuals are needed from one research centre."
Are there any spots left for participants in this clinical experiment?
"Clinicaltrials.gov documents that this clinical trial is active and recruiting, having first been posted on 12/1/2020 with the most recent edit made on 5/10/2022."
Has this particular treatment obtained regulatory endorsement from the FDA?
"The safety of the proposed intervention is estimated at a 2 because this is just a Phase 2 clinical trial, meaning there only exists some evidence supporting its security but none regarding efficacy."
Share this study with friends
Copy Link
Messenger